• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Response of motor complications in Cockayne syndrome to carbidopa-levodopa.

作者信息

Neilan Edward G, Delgado Mauricio R, Donovan Melissa A, Kim Sara Y, Jou Rita L, Wu Bai-Lin, Kang Peter B

机构信息

Division ofGenetics, Children's Hospital Boston, Boston, MA 02115, USA.

出版信息

Arch Neurol. 2008 Aug;65(8):1117-21. doi: 10.1001/archneur.65.8.1117.

DOI:10.1001/archneur.65.8.1117
PMID:18695064
Abstract

BACKGROUND

Gait difficulties, tremors, and coordination difficulties are common features of Cockayne syndrome that are consequences of leukodystrophy, cerebellar atrophy, and demyelinating neuropathy, but no pharmacotherapy for these disabling symptoms is available.

OBJECTIVE

To determine whether carbidopa-levodopa relieves tremors and other motor complications of Cockayne syndrome.

DESIGN

Mutation analysis and case report study.

SETTING

Hospital clinic and genetics research laboratory. Patients We studied 3 patients with Cockayne syndrome, a rare autosomal recessive neurodegenerative disorder for which no known treatments are available. Intervention Carbidopa-levodopa therapy.

MAIN OUTCOME MEASURES

Status of tremors, ability to perform daily tasks, serial physical examinations, and results of handwriting samples.

RESULTS

All 3 patients had a clear reduction in tremors and improvements in handwriting and manipulation of utensils and cups.

CONCLUSIONS

Patients with Cockayne syndrome should be evaluated carefully for movement disorders. A clinical trial should be considered to evaluate this therapy further.

摘要

相似文献

1
Response of motor complications in Cockayne syndrome to carbidopa-levodopa.
Arch Neurol. 2008 Aug;65(8):1117-21. doi: 10.1001/archneur.65.8.1117.
2
Rehabilitation of patients with Hallervorden-Spatz syndrome.
Arch Phys Med Rehabil. 1993 Mar;74(3):328-9.
3
Enteral levodopa/carbidopa infusion in advanced Parkinson disease: long-term exposure.晚期帕金森病患者肠内左旋多巴/卡比多巴输注:长期暴露情况
Clin Neuropharmacol. 2008 Mar-Apr;31(2):63-73. doi: 10.1097/WNF.0b013e3180ed449f.
4
Reducing dosing frequency of carbidopa/levodopa: double-blind crossover study comparing twice-daily bilayer formulation of carbidopa/levodopa (IPX054) versus 4 daily doses of standard carbidopa/levodopa in stable Parkinson disease patients.降低卡比多巴/左旋多巴的给药频率:双盲交叉研究,比较卡比多巴/左旋多巴每日两次双层制剂(IPX054)与稳定期帕金森病患者每日4次标准卡比多巴/左旋多巴的疗效。
Clin Neuropharmacol. 2009 Jul-Aug;32(4):189-92. doi: 10.1097/WNF.0b013e3181a27fae.
5
The syndrome of gait ignition failure: a report of six cases.步态启动失败综合征:6例报告
Mov Disord. 1993 Jul;8(3):285-92. doi: 10.1002/mds.870080306.
6
Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.普拉克索与左旋多巴起始治疗对早期帕金森病的长期影响。
Arch Neurol. 2009 May;66(5):563-70. doi: 10.1001/archneur.66.1.nct90001.
7
[Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].[多多巴持续多巴胺能刺激治疗晚期帕金森病:疗效与安全性]
Rev Neurol (Paris). 2009 Aug-Sep;165(8-9):718-27. doi: 10.1016/j.neurol.2008.11.017. Epub 2009 Jan 15.
8
A pilot trial of levodopa/carbidopa in early cocaine abstinence.
J Clin Psychopharmacol. 1990 Dec;10(6):440-2.
9
Carbidopa-levodopa therapy for movement disorders.
Arch Phys Med Rehabil. 1987 Oct;68(10):745-6.
10
Short- and long-term approaches to the "on-off" phenomenon.“开-关”现象的短期和长期应对方法。
Adv Neurol. 1974;5:379-86.

引用本文的文献

1
Cognitive Decline and Other Late-Stage Neurologic Complications in Cockayne Syndrome.科凯恩综合征中的认知衰退及其他晚期神经并发症
Neurol Clin Pract. 2024 Aug;14(4):e200309. doi: 10.1212/CPJ.0000000000200309. Epub 2024 May 16.
2
A Case of ERCC6-Related Cockayne Syndrome Presenting with Levodopa-Responsive Tremor Syndrome.1例与ERCC6相关的科凯恩综合征伴左旋多巴反应性震颤综合征
Mov Disord Clin Pract. 2023 Oct 9;10(12):1818-1820. doi: 10.1002/mdc3.13898. eCollection 2023 Dec.
3
Cockayne syndrome type 3 with dystonia-ataxia and clicking blinks.
伴有肌张力障碍 - 共济失调和瞬目抽搐的3型科凯恩综合征
Mov Disord Clin Pract. 2023 Aug 24;10(Suppl 3):S48-S50. doi: 10.1002/mdc3.13778. eCollection 2023 Aug.
4
Peripheral neuropathies associated with DNA repair disorders.与 DNA 修复障碍相关的周围神经病。
Muscle Nerve. 2023 Feb;67(2):101-110. doi: 10.1002/mus.27721. Epub 2022 Oct 3.
5
Whole Exome Sequencing Identifies a Novel Homozygous Missense Mutation in the CSB Protein-Encoding Gene in a Taiwanese Boy with Cockayne Syndrome.全外显子组测序在一名患有科凯恩综合征的台湾男孩的CSB蛋白编码基因中鉴定出一种新的纯合错义突变。
Life (Basel). 2021 Nov 14;11(11):1230. doi: 10.3390/life11111230.
6
Xeroderma pigmentosum-Cockayne syndrome complex.着色性干皮病-科凯恩综合征复合体
Orphanet J Rare Dis. 2017 Apr 4;12(1):65. doi: 10.1186/s13023-017-0616-2.
7
Cockayne syndrome: Clinical features, model systems and pathways.科凯恩综合征:临床特征、模型系统与通路
Ageing Res Rev. 2017 Jan;33:3-17. doi: 10.1016/j.arr.2016.08.002. Epub 2016 Aug 6.
8
The Cockayne Syndrome Natural History (CoSyNH) study: clinical findings in 102 individuals and recommendations for care.科凯恩综合征自然史(CoSyNH)研究:102例个体的临床发现及护理建议。
Genet Med. 2016 May;18(5):483-93. doi: 10.1038/gim.2015.110. Epub 2015 Jul 23.
9
Blinded by the UV light: how the focus on transcription-coupled NER has distracted from understanding the mechanisms of Cockayne syndrome neurologic disease.被紫外线蒙蔽了双眼:为什么转录偶联核苷酸切除修复的研究重点分散了人们对 Cockayne 综合征神经疾病机制的理解。
DNA Repair (Amst). 2013 Aug;12(8):656-71. doi: 10.1016/j.dnarep.2013.04.018. Epub 2013 May 16.